Third Harmonic Bio Inc. (THRD) Social Stream
THIRD HARMONIC BIO INC (THRD) Price Targets From Analysts
Use the tables below to see what analysts covering THIRD HARMONIC BIO INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-10-10 | 4 | $39 | $30 | $34.333 | $10.98 | 212.69% |
| 2022-11-10 | 4 | $39 | $30 | $34.333 | $10.98 | 212.69% |
| 2022-12-15 | 4 | $39 | $5 | $24.666 | $10.98 | 124.64% |
| 2023-05-12 | 4 | $5 | $3.6 | $4.3 | $10.98 | -60.84% |
| 2023-07-25 | 4 | $5 | $3.6 | $4.3 | $10.98 | -60.84% |
| 2023-11-10 | 4 | $7 | $3.6 | $5.3 | $10.98 | -51.73% |
| 2023-12-19 | 4 | $11 | $3.6 | $7.3 | $10.98 | -33.52% |
| NA | 4 | $NA | $NA | $NA | $10.98 | NA% |
The Trend in the Analyst Price Target
Over the past 147 days, THRD's average price target has gone up $3.
THRD reports an average of -17.82% for its upside potential over the past 32 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-05-12 | 4 | 5 | 3.6 | 4.3 | 4.74 | -9.28% |
| 2023-07-25 | 4 | 5 | 3.6 | 4.3 | 5.60 | -23.21% |
| 2023-08-10 | 4 | 7 | 3.6 | 5.3 | 6.24 | -15.06% |
| 2023-11-10 | 4 | 7 | 3.6 | 5.3 | 6.04 | -12.25% |
| 2023-12-19 | 4 | 11 | 3.6 | 7.3 | 10.92 | -33.15% |
THRD Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2 | 2 | 0 | 2 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
THRD's average broker recommendation rating improved by 0.5 over the prior 52 weeks.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how THIRD HARMONIC BIO INC fares relative to all US stocks, note that its number of analysts covering the stock is higher than 79.98% of that group.
- To contextualize these metrics, consider that out of all US stocks, THIRD HARMONIC BIO INC's upside potential (average analyst target price relative to current price) is higher than 175.24% of them.
- To contextualize these metrics, consider that out of stocks in the small market cap category, THIRD HARMONIC BIO INC's average analyst price target is greater than 179.43% of them.
- To contextualize these metrics, consider that out of Healthcare stocks, THIRD HARMONIC BIO INC's variance in analysts' estimates is lower than -166.26% of them.
In the Pharmaceutical Products industry, GNLX, MLYS, and DYAI are the three stocks most similar to THIRD HARMONIC BIO INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is THRD a Buy, Hold or Sell? See the POWR Ratings now!